Strong Patient Network SubjectWell boasts a growing patient network of over 13 million individuals across 102 countries, providing a substantial and diverse pool for patient recruitment. This extensive reach can be leveraged by pharmaceutical companies and CROs seeking efficient enrollment solutions for global clinical trials.

Award-Winning Platform The company has been recognized with multiple awards including the 2025 Clinical Trials Arena Marketing Award and the GDUSA Health + Wellness Design Award, highlighting their innovative, patient-centric approach and strong brand presence. Such recognition can be a compelling selling point to prospects valuing proven industry credibility.

Technology-Driven Solutions Utilizing a sophisticated tech stack including Teradata, Salesforce, and Google Ads, SubjectWell demonstrates a strong emphasis on data analytics and digital marketing. This tech focus positions them well to support sponsors and CROs in optimizing recruitment campaigns through advanced data insights and automation.

Appealing Financials With revenues between $25 million and $50 million and $35 million in funding, SubjectWell has a solid financial foundation and growth potential. This stability can make them an attractive partner for businesses looking for reliable, innovative patient recruitment services in a competitive market environment.